Skip to main content
Log in

Comparison of antagonistic ability against enteropathogens by G+ and G anaerobic dominant components of human fecal microbiota

  • Published:
Folia Microbiologica Aims and scope Submit manuscript

Abstract

To confirm if anaerobic G+-components are those responsible for the function of colonization resistance, obligate anaerobic G+- and G-bacteria from normal dominant microbiota of human feces were isolated from three successive collections and then used inin vitro assays for antagonism against two enteropathogenic bacteria. The production of inhibitory diffusible compounds was determined on supplemented BHI agar and MRS agar media for G- and G+-bacteria, respectively.Salmonella enterica subsp.enterica serovar Typhimurium andShigella sonnei were used as indicators. G+-bacteria presented a higher overall antagonistic frequency against both pathogenic bacteria (57 and 64 % forS. enterica serovar Typhimurium andS. sonnei, respectively) when compared to G+-microorganisms but with a quite elevated variation between volunteers (0–100 %) and collection samples (40–72 and 40–80 % forS. enterica sv. Typhimurium andS. sonnei, respectively). On the other hand, only three among 143 G-isolates tested showed antagonistic activity. The results showed that, at leastin vitro, obligate anaerobic G+-components of the dominant human fecal microbiota present a higher potential for antagonism against the enteropathogenic models tested than do G-bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Berg R.D.: The indigenous gastrointestinal microflora.Trends Microbiol.4, 430–435 (1996).

    Article  PubMed  CAS  Google Scholar 

  • Dubos R.: The composition of the indigenous microbiota, pp. 110–128 in R. Dubos (Ed.):Man Adapting, 5th ed. Yale University Press, New Haven (USA) 1965.

    Google Scholar 

  • Duval-Iflah Y., Raibaud P., Rousseau M.: Antagonisms among isogenic strains ofEscherichia coli in the digestive tracts of gnotobiotic mice.Infect.Immun.34, 957–969 (1981).

    PubMed  CAS  Google Scholar 

  • Farias L.M., Totola A.H., Miranda C.M.S., Carvalho M.A.R., Damasceno C.A.V., Tavares C.A.P., Cisalpino E.O., Vieira E.C.: Extraction, partial purification and characterization of a bacteriocin (fragilicin) produced by a strain of aBacteroides fragilis isolated fromCallithrix penicillata.Res.Microbiol.145, 9–16 (1994).

    Article  PubMed  CAS  Google Scholar 

  • Freter R.: Experimental enteric shigella and vibrio infections in mice and guinea pigs.J.Exp.Med.104, 411–418 (1956).

    Article  PubMed  CAS  Google Scholar 

  • Höhme C., Neumann D., Jentzschen M.: Antimicrobial activities of black-pigmented Gram-negative anaerobes.FEMS Immunol.Med.Microbiol.6, 235–240 (1993).

    Article  Google Scholar 

  • Kaper J.B., Sperandio V.: Bacterial cell-to-cell signaling in the gastrointestinal tract.Infect.Immun.73, 3197–3209 (2005).

    Article  PubMed  CAS  Google Scholar 

  • Kozáková H., Reháková Z., Kolínská J.:Folia Microbiol.46, 573–576 (2001).

    Article  Google Scholar 

  • Krueger W.A., Unertl K.E.: Selective decontamination of the digestive tract.Curr.Opin.Crit.Care8, 139–144 (2002).

    Article  PubMed  Google Scholar 

  • Lee Y.J., Yu W.K., Heo T.R.: Identification and screening for microbial activity againstClostridium difficile of Bifidobacterium andLactobacillus species isolated from healthy infant faeces.Internat.J.Antimicrob.Agents21, 340–346 (2003).

    Article  CAS  Google Scholar 

  • Liévin V., Peiffer I., Hudault S., Rochat F., Brassart D., Neeser J.-R., Servin A.L.:Bifidobacterium strains from resident infant human gastrointestinal microflora exert antimicrobial activity.Gut47, 646–652 (2000).

    Article  PubMed  Google Scholar 

  • Livingston S.J., Kominossp P., Yee R.B.: New medium for selective and presumptive identification of theBacteroides fragilis group.J.Clin.Microbiol.7, 448–453 (1978).

    PubMed  CAS  Google Scholar 

  • MacCartney A.L., Wenzhi W., Tannock G.W.: Molecular analysis of the composition of the bifidobacterial andLactobacillus microflora of humans.Appl.Environ.Microbiol.62, 4608–4613 (1996).

    Google Scholar 

  • MacFarland L.V.: Normal flora: diversity and functions.Microb.Ecol.Health Dis.12, 193–207 (2000).

    Article  Google Scholar 

  • Nardi R.D., Santos A.R.M., Carvalho M.A.R., Farias L.M., Benchetrit L.C., Nicoli J.R.: Antagonism against anaerobic and facultative bacteria through a diffusible inhibitory compound produced by aLactobacillus sp. isolated from rat fecal microbiota.Anaerobe5, 409–411 (1999).

    Article  Google Scholar 

  • Oliveira A.A.P., Farias L.M., Nicoli J.R., Costa J.E., Carvalho M.A.R.: Bacteriocin production byFusobacterium isolates recovered from the oral cavity of human subjects with and without periodontal disease and of marmosets.Res.Microbiol.149, 585–594 (1998).

    Article  PubMed  CAS  Google Scholar 

  • Ramar F., Nicoli J.R., Dabard J., Corring T., Ladir M., Gueugneau A.-M., Raibaud P.: Trypsin-dependent production of an antibacterial substance by a humanPeptostreptococcus strain in the gnotobiotic rats andin vitro.Appl.Environ.Microbiol.59, 2876–2883 (1993).

    Google Scholar 

  • Reuter G.: TheLactobacillus andBifidobacterium microflora of the human intestine: composition and succession.Curr.Issues Intest.Microbiol.2, 43–53 (2001).

    PubMed  CAS  Google Scholar 

  • Servin A.L.: Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens.FEMS Microbiol.Rev.28, 405–440 (2004).

    Article  PubMed  CAS  Google Scholar 

  • Silva S.H., Vieira E.C., Nicoli J.R.: Antagonism againstVibrio cholerae by bacterial diffusible compound in the fecal microbiota of rodents.Rev.Microbiol.29, 228–233 (1998).

    Google Scholar 

  • Silva S.H., Vieira E.C., Dias R.S., Nicoli J.R.: Antagonism againstVibrio cholerae by diffusible substances produced by bacterial components of the human faecal microbiota.J.Med.Microbiol.50, 161–164 (2001).

    PubMed  CAS  Google Scholar 

  • Sullivan D.J.O.: Screening of intestinal microflora for effective probiotic bacteria.J.Agric.Food Chem.49, 1751–1760 (2001).

    Article  CAS  Google Scholar 

  • Tannock G.W., Tilsala-Timisjarvi A., Rodtong S., Ng J., Munro K., Alatossava T.: Identification ofLactobacillus isolates from the gastrointestinal tract, silage, and yoghurt by 16S–26S rRNA gene intergenic spacer region sequence comparisons.Appl.Environ.Microbiol.65, 4264–4267 (1999).

    PubMed  CAS  Google Scholar 

  • Teitelbaum J.E., Walker W.A.: Nutritional impact of pre- and probiotics as protective gastrointestinal organisms.Ann.Rev.Nutr.22, 107–138 (2002).

    Article  CAS  Google Scholar 

  • Toure R., Kheadr E., Lacroix C., Moroni O., Fliss I.: Production of antibacterial substances by bifidobacterial isolates form infant stool active againstListeria monocytogenes.J.Appl.Microbiol.95, 1058–1069 (2003).

    Article  PubMed  CAS  Google Scholar 

  • Van der Waaij D.: Colonization pattern of the digestive tract by potentially pathogenic microorganisms: colonization-controlling mechanisms and consequences for antibiotic treatment.Infection11, S90-S92 (1983).

    Article  PubMed  Google Scholar 

  • Vlková E., Rada V., Bujňáková D., Kmeť V.: Enumeration, isolation, and identification of bifidobacteria from infant feces.Folia Microbiol.49, 209–212 (2004).

    Article  Google Scholar 

  • Zoetendal E.G., Akkermans A.D., de Vos W.M.: Temperature gradient gel electrophoresis analysis of 16S rRNA from human fecal samples reveals stable and host-specific communities of active bacteria.Appl.Environ.Microbiol.64, 3854–3859 (1998).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. R. Nicoli.

Additional information

This work was supported by grants fromConselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),Fundação de Amparo à Pesquisa do Estado de Minas Gerais (FAPEMIG) andCoordenação de Aperfeiçoamento de Pessoal de Nivel Superior (CAPES).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gomes, D.A., Souza, A.M.L., Lopes, R.V. et al. Comparison of antagonistic ability against enteropathogens by G+ and G anaerobic dominant components of human fecal microbiota. Folia Microbiol 51, 141–145 (2006). https://doi.org/10.1007/BF02932170

Download citation

  • Received:

  • Revised:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02932170

Keywords

Navigation